Cachexia is a cancer-associated metabolic syndrome that causes muscle spoliation, which leads to a reduced life quality of cancer patients. Maternal nutritional supplementation with the branched-chain amino acid leucine has been studied as an attempt to minimise/prevent the muscle waste, as an epigenetic effect from pregnancy and weaning periods during the environment modulatory role. Metabolomic analysis is an important technique to evaluate the preventive effects of maternal nutritional supplementation in a cachexia process. Thus, the present study analysed the possible regulatory effects of this supplementation on muscle metabolic profile of the adult offspring rats bearing a Walker-256 tumour. The skeletal muscle (gastrocnemius) was processed by 1H-NMRI analysis to determine the metabolomic profiles. The tumour-bearing rats were spoiled and had an increased muscle energy expenditure. The maternal leucine supplementation improved the energy availability for muscle function and activity.
Introduction
Cancer is a set of diseases responsible for the death of 1 in 6 people around the world. Cachexia is an associated multifactorial metabolic syndrome, marked by muscle spoliation, which can reduce the life quality in cancer patients. Maternal nutritional supplementation with the branched-chain amino acid leucine has been studied as an attempt to counteract the damages caused by cachexia, ameliorating the loss of muscle mass, and also in a preventive way, since epigenetic alterations occurred by environmental modulating role during the periods of pregnancy and weaning. The nuclear magnetic resonance ( 1 H-NMR) is an important tool to analyse the metabolic profile, identifying changes presented in cachexia state. 
Results and Discussion

Conclusions
The 1H-NMRI analyses showed the energy expenditure impacted by tumour evolution, which led to a muscle tissue jeopardise; counteracting, the maternal nutritional supplementation with leucine attenuated the catabolic state of cachexia.
